STR (Steps to Recovery), which is based in PA, has just announced an innovative tech addition which will be incorporated into its addictive behavior treatment approach. This is referred to as the GARS® test. Formulated by MyGenx®, GARS® is classified as the original and only patented genetic test which can identify an individuals’s risk toward non-substance and substance behavior.
A Highly Beneficial, Simple Test
The GARS® test, which is conducted using a non-invasive cheek swab, distinguishes an individual’s risk to many different non-substance and substance behaviors. These comprise: gambling, online gaming, stimulants, opioids, alcohol, and more . Having this knowledge can make a very positive difference to addicts, and can also help their doctors and therapists.
Making Use of New Science
Finally, addicts are being helped by science, and now, Steps to Recovery will be adding this personalized GARS® test to their treatment protocols. The company’s CEO, Ryan McCarthy, remarked that: “As we continue to expand our understanding of addiction and learn about new, innovative practices, we are constantly looking for ways to enhance the care that we provide to our patients”. McCarthy also said that this breakthrough personalizes the STR programs, yet one step further.
Providing Early Intervention
The GARS® test’s strongest value, is that with regard to addictive behavior and genetics, the latter only accounts for half the equation. – An individual’s exposure to risk or environment, constitutes the other fifty percent. Yet unfortunately, at the present time, most of the population spend their entire lives being unaware of their risks toward non-substance or substance behaviors. But once people are in the know, then they have the means to make important transformations to their lives, so that they can reduce and combat the triggers that cause so many serious problems
Challenging the Stigma to Addiction
STR’c Clinical Director, Manuel Rivera, is determined to play a key role in helping to eliminate the stigma that addicts of all kinds face, by offering interventions as soon as possible. Rivera stated: “We want to work with our community partners, school districts, local PTOs, local townships, county municipalities, church groups, and anyone with a larger reach to get the word out about early steps that we can take”.
Kristina Kipp, PharmD, who is connected to Philadelphia’s globally-renowned academic medical center, is a huge supporter of this exciting state-of-the-art form of tech. She notes that: “Addiction is a complex disorder, and the more information we can obtain, the better decisions healthcare providers can make, to offer the most optimal treatment. Just like with any disease state out there, the best way to tackle it, is through prevention. I think it is outstanding what Steps to Recovery is doing on the preventative side. Think alone how this could impact the opioid addiction crisis, by better informing providers of a patient’s potential risk for addiction”.
Hopefully, GARS® will make its mark in the great battle for addition which has, up until now, plagued millions of people from all walk of life, all over the world.